GALECTIN THERAPEUTICS INC - FORM 10-K - EX-23.1 - CONSENT OF MCGLADREY & PULLEN, LLP - March 15, 2011

Attached files

file filename
10-K - FORM 10-K - GALECTIN THERAPEUTICS INCd10k.htm
EX-31.2 - CERTIFICATION OF CFO PURSUANT TO SECTION 302 - GALECTIN THERAPEUTICS INCdex312.htm
EX-32.1 - CERTIFICATION OF CEO AND PRESIDENT PURSUANT TO SECTION 906 - GALECTIN THERAPEUTICS INCdex321.htm
EX-21.1 - SUBSIDIARIES OF PRO PHARMACEUTICALS, INC. - GALECTIN THERAPEUTICS INCdex211.htm
EX-32.2 - CERTIFICATION OF CFO PURSUANT TO SECTION 906 - GALECTIN THERAPEUTICS INCdex322.htm
EX-23.2 - CONSENT OF CATURANO AND COMPANY, INC. - GALECTIN THERAPEUTICS INCdex232.htm
EX-31.1 - CERTIFICATION OF CEO AND PRESIDENT PURSUANT TO SECTION 302 - GALECTIN THERAPEUTICS INCdex311.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in Registration Statement Nos. 333-116629, 333-109893 and 333-159247 on Form S-8 of our report dated March 15, 2011 (which report expresses an unqualified opinion), appearing in this Annual Report on Form 10-K of Pro-Pharmaceuticals, Inc. for the year ended December 31, 2010.

/s/ McGladrey & Pullen, LLP

Boston, Massachusetts

March 15, 2011

Stock widget

Investing forum

GALECTIN THERAPEUTICS INC Reports